Mediaboss Marketing

4:28

Graviola Tree - A Natural Cancer Cell Killer

Graviola Tree - A Natural Cancer Cell Killer

It's been called a miracle tree. Indigenous peoples from the Amazon jungle have used the bark, leaves, roots, flowers, fruit, and seed from the graviola tree for centuries to treat heart disease, asthma, liver problems, and arthritis. Scientists from North America learned of the legendary healing tree and, through dozens of in vitro tests, discovered its ability to kill malignant cells of 12 different types of cancer, including ovarian, colon, breast, prostate, lung, liver, cervical, lymphoma, and pancreatic cancer. Laboratory research showed it to be 10000 times stronger in killing colon cancer cells than Adriamycin, a commonly used chemotherapy drug. And Graviola, unlike chemotherapy, can kill cancer cells without harming healthy cells. http://www.naturalnews.com health.howstuffworks.com This video may contain copyrighted material. Such material is made available for educational purposes only..

8:02

Rave Diet Eating Dvd With Mike Anderson, Cure Cancer Naturally

Rave Diet Eating Dvd With Mike Anderson, Cure Cancer Naturally

FOR MORE INFO VISIT davetravis7.blogspot.com The Rave Diet, shows how cancer can be successfully healed with dietary treatments and natural supplementation. It explains common misconceptions about cancer, shows how diets designed to fight cancer are more successful than conventional treatments, discusses startling cancer research findings with T. Colin Campbell (The China Study) and has interviews with people who have reversed cancers using diet. It also discusses supplementation and why attitude is important in reversing not only cancer, but any disease. Dr. Crowe and Dr. Esselstyn are from the world-famous Cleveland Clinic Foundation and know something about heart disease. In fact, Dr. Esselstyn directed the longest and most successful heart disease reversal program ever. These interviews will convince you that cardiovascular (heart) disease, the #1 killer in America today, can be reversed by switching to The Rave Diet. What you will get is a virtual one-on-one consultation with some of the world's leading authorities on heart disease reversal. Dr. Pinckney and Dr. Crowe both reversed severe heart disease by adopting The Rave Diet. If you know someone with heart disease - who doesn't? - this will probably be the most valuable film they will ever watch - and from authorities with impeccable credentials. And if you eat to prevent heart disease, you will also prevent the other major chronic diseases that are plaguing Western nations. You will also hear from Dr. Heidrich ...

1:09

Human ' Treeman ' begs for help as he turns into a tree.

See more here:
Carvajal: Killer diseases

PARIS Scientists said Sunday they had found a key piece in the puzzle as to why a tiny minority of individuals infected with HIV have a natural ability to fight off the deadly AIDS virus.

In a study they said holds promise for an HIV vaccine, researchers from four countries noted the secret lies not in the number of infection-killing cells one has, but in how well they work.

Only about one person in 300 has the ability to control the human immunodeficiency virus without drugs, using "killer" cells called cytotoxic T lymphocyte cells, past research found.

Taking that discovery further, scientists from the United States, Canada, Japan and Germany reported that the strain has molecules called receptors that are better able to identify HIV-infected white blood cells for attack.

Until now, it was well known that people with HIV "have tons of these killer cells," said Bruce Walker, an infectious diseases expert at the Ragon Institute in Massachusetts.

"We have been scratching our heads since then, asking how, with so many killer cells around, people are getting AIDS. It turns out there is a special quality that makes them (some cells) better at killing."

The study looked at 10 infected people, of whom five took antiretroviral drugs to keep HIV under control while five were so-called elite controllers who remained naturally healthy.

HIV kills a type of white blood cell called CD4, leaving people with AIDS wide open to other, opportunistic and potentially deadly infections.

"What we found was that the way the killer cells are able to see infected cells and engage them was different," said Walker.

"It is not just that you need a killer cell, what you need is a killer cell with a (T cell) receptor that is particularly good at recognizing the infected cell. This gives us a way to understand what it is that makes a really good killer cell."

More:
HIV has natural-born killers, researchers find

Researchers have shown that a cold virus known to destroy cancer cells can be delivered to a tumour through the bloodstream without falling prey to killer antibodies on the way.

In a study published Wednesday in the journal Science Translational Medicine, the researchers found the "reovirus" hitches a ride on blood cells and uses them as a shield against the immune-system cells.

The reovirus holds promise as a possible new way of treating cancer because it not only kill cancer cells directly, but also triggers an immune response similar to what a vaccine does that helps eliminate residual cancer cells.

But because the virus, which causes upper respiratory and gastrointestinal illness, is common in the environment, most people have been exposed to it in childhood and therefore have developed antibodies, said Alan Melcher, a professor of clinical oncology and biotherapy at the University of Leeds who co-led the study.

"What people thought that meant was that if you've got antibodies against the virus, if you just inject it into the bloodstream, it can never work because it will just be neutralized by the antibodies," Melcher said Wednesday from Leeds, England.

"But what we were able to show, actually, was that by associating with blood cells in the blood, the virus can effectively hide from the antibodies and therefore get transported through the circulation and so get to the tumour."

The study involved 10 patients with advanced colorectal cancer who were due to have surgery on tumours that had spread to the liver. All patients were given up to five intravenous doses of the reovirus in the weeks before their operations.

Blood tests carried out shortly after treatment found the active virus tagging along with blood cells, but later tests showed the virus was quickly cleared from the bloodstream.

However, when researchers looked at the malignant liver tissue removed during surgery up to four weeks later, they found "viral factories" and active virus in the tumour but not in normal liver tissue.

"It seems that reovirus is even cleverer than we had thought. By piggybacking on blood cells, the virus is managing to hide from the body's natural immune response and reach its target intact," Melcher said. "This could be hugely significant for the uptake of viral therapies like this in clinical practice."

See the original post here:
Cold virus holds promise as tumour-fighting cancer therapy

Date: Wednesday Jun. 13, 2012 3:37 PM ET

Researchers have shown that a cold virus known to destroy cancer cells can be delivered to a tumour through the bloodstream without falling prey to killer antibodies on the way.

In a study published Wednesday in the journal Science Translational Medicine, the researchers found the "reovirus" hitches a ride on blood cells and uses them as a shield against the immune-system cells.

The reovirus holds promise as a possible new way of treating cancer because it not only kill cancer cells directly, but also triggers an immune response -- similar to what a vaccine does -- that helps eliminate residual cancer cells.

But because the virus, which causes upper respiratory and gastrointestinal illness, is common in the environment, most people have been exposed to it in childhood and therefore have developed antibodies, said Alan Melcher, a professor of clinical oncology and biotherapy at the University of Leeds who co-led the study.

"What people thought that meant was that if you've got antibodies against the virus, if you just inject it into the bloodstream, it can never work because it will just be neutralized by the antibodies," Melcher said Wednesday from Leeds, England.

"But what we were able to show, actually, was that by associating with blood cells in the blood, the virus can effectively hide from the antibodies and therefore get transported through the circulation and so get to the tumour."

The study involved 10 patients with advanced colorectal cancer who were due to have surgery on tumours that had spread to the liver. All patients were given up to five intravenous doses of the reovirus in the weeks before their operations.

Blood tests carried out shortly after treatment found the active virus tagging along with blood cells, but later tests showed the virus was quickly cleared from the bloodstream.

However, when researchers looked at the malignant liver tissue removed during surgery up to four weeks later, they found "viral factories" and active virus in the tumour -- but not in normal liver tissue.

Continued here:
Cold virus holds promise as cancer therapy: study

Researchers have shown that a cold virus known to destroy cancer cells can be delivered to a tumour through the bloodstream without falling prey to killer antibodies on the way.

In a study published Wednesday in the journal Science Translational Medicine, the researchers found the reovirus hitches a ride on blood cells and uses them as a shield against the immune-system cells.

The reovirus holds promise as a possible new way of treating cancer because it not only kills cancer cells directly, but also triggers an immune response similar to what a vaccine does that helps eliminate residual cancer cells.

But because the virus, which causes upper respiratory and gastrointestinal illness, is common in the environment, most people have been exposed to it in childhood and therefore have developed antibodies, said Alan Melcher, a professor of clinical oncology and biotherapy at the University of Leeds in England, who co-led the study.

What people thought that meant was that if youve got antibodies against the virus, if you just inject it into the bloodstream, it can never work because it will just be neutralized by the antibodies, Melcher said Wednesday from Leeds. But what we were able to show, actually, was that by associating with blood cells in the blood, the virus can effectively hide from the antibodies and therefore get transported through the circulation and so get to the tumour.

The study involved 10 patients with advanced colorectal cancer who were due to have surgery on tumours that had spread to the liver. All patients were given up to five intravenous doses of the reovirus in the weeks before their operations.

Blood tests carried out shortly after treatment found the active virus tagging along with blood cells, but later tests showed the virus was quickly cleared from the bloodstream.

However, when researchers looked at the malignant liver tissue removed during surgery up to four weeks later, they found viral factories and active virus in the tumour but not in normal liver tissue.

It seems that reovirus is even cleverer than we had thought. By piggybacking on blood cells, the virus is managing to hide from the bodys natural immune response and reach its target intact, Melcher said. This could be hugely significant for the uptake of viral therapies like this in clinical practice.

The study was not intended to see if the reovirus can shrink or eliminate tumours that question is being explored in much larger trials of patients with a variety of cancers but it does provide proof-of-concept that intravenously delivered reovirus-based cancer therapy is possible, he said.

Read this article:
Virus’s tricks may used to beat cancer